12 March 2002
Resistance of Klebsiella pneumoniae strains producing and not producing ESBL(extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.Maria Szymankiewicz, Marcin Wróblewski, Grazyna Janicka, Alicja Sekowska, Małgorzata Wojda, Czesław Kłyszejko
Med Sci Monit 2002; 8(3): BR100-104 :: ID: 420891
BACKGROUND: Bacteria of the Klebsiella genus may cause numerous infectionsin human, which are often treated with beta-lactam antibiotics. The fundamental mechanism of Klebsiellaresistance to penicillins or cephalosporins involves the production of enzymes--extended-spectrum beta-lactamases(ESBLs). Because of resistance of many Klebsiella spp. strains to beta-lactams, alternative antibiotictherapy can make use of aminoglycosides and quinolones. MATERIAL/METHODS: The study analyzed the prevalenceof ESBL -type enzymes among 256 Klebsiella pneumoniae strains isolated from various clinical materialscollected from patients hospitalized between 1997 and 2000. ESBLs were detected by double-disk synergytest (DDST). The prevalence of strains resistant to selected aminoglycosides (gentamicin, amikacin, netilmicin)and quinolones (ciprofloxacin, norfloxacin, nalidixic acid) in the particular years was analyzed. Drugsensitivity was determined by disk-diffusion method according to the recommendations of the NationalReference Center for Microbial Drug Sensitivity. RESULTS: During the analyzed time interval, a significantincrease of the number of K. pneumoniae ESBL(+) strains was noted: in 1997 - 16.5% (14/85) and in 2000- 40.4% (22/54) (p<0.001).Among the ESBL(+) strains, an increase of the number of strains resistant to the tested antibiotics, except for nalidixic acid, was demonstrated
Conclusion: A statistically significant increase of multidrug-resistant K. pneumoniae strains, including strains producing ESBLs, was demonstrated in the analyzed material
Keywords: amikacin, Anti-Bacterial Agents, Anti-Infective Agents, Ciprofloxacin, Drug Resistance, Microbial, Gentamicins, Klebsiella pneumoniae, Microbial Sensitivity Tests, Nalidixic Acid, Netilmicin, Norfloxacin, Prevalence, Time Factors, beta-Lactamases
01 February 2023 : EditorialEditorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread
Med Sci Monit 2023; 29:e939580
19 January 2023 : Clinical ResearchEvaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...
Med Sci Monit In Press; DOI: 10.12659/MSM.938892
19 January 2023 : Clinical ResearchDetermining the Impact of the COVID-19 Pandemic on Dental Care in the Serbian Adult Population: An Online Q...
Med Sci Monit 2023; 29:e939238
27 December 2022 : Clinical ResearchEffect of Physiotherapy to Correct Rounded Shoulder Posture in 30 Patients During the COVID-19 Pandemic in ...
Med Sci Monit 2022; 28:e938926
07 Feb 2023 : Clinical ResearchApplication of Musculoskeletal Ultrasound Guidance in Lumbar Transforaminal Endoscopic Surgery for Puncture...
Med Sci Monit In Press; DOI: 10.12659/MSM.937692
07 Feb 2023 : Clinical ResearchEffect of Polylactic Acid Membrane on Guided Bone Regeneration in Anterior Maxillary Implantation
Med Sci Monit In Press; DOI: 10.12659/MSM.938566
06 Feb 2023 : Clinical ResearchDouble C-Arm Digital Subtraction Angiography Guidance During Transjugular Intrahepatic Portosystemic Shunt ...
Med Sci Monit In Press; DOI: 10.12659/MSM.938912
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292